.

Pharmaceutical Business Intelligence

  • Anticipate P&T budget requirements
  • Evaluate market entry opportunities
  • Find generic sources and suppliers
  • Predict branded drug patent expiration

► Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

DrugPatentWatch Database Preview

Claims for Patent: 9,023,401

« Back to Dashboard

Claims for Patent: 9,023,401

Title:Controlled release hydrocodone formulations
Abstract: A solid oral controlled-release dosage form of hydrocodone is disclosed, the dosage form comprising an analgesically effective amount of hydrocodone or a pharmaceutically acceptable salt thereof, and controlled release material.
Inventor(s): Oshlack; Benjamin (Boca Raton, FL), Huang; Hua-Pin (Englewood Cliffs, NJ), Masselink; John K. (Old Tappan, NJ), Tonelli; Alfred (Congers, NY)
Assignee: Purdue Pharma L.P. (Stamford, CT)
Application Number:14/581,175
Patent Claims: 1.sup.th edition," 1989, Merck & Co. CP002606249. cited by applicant .
Merk Index, 13.sup.th edition, entry 4806: hydrocodone (2001). cited by applicant .
EPI Journal Feb. 2007, pp. 59-60; David Harrison; "Divisional Application a continuing problem" (2007). cited by applicant .
Document CA/PL 17/07; "Misuse of Divisional Applications," by the EPO President, addressed to the EPO Committee of Patent Law. Presented at the EPO Administrative Council, dated Oct. 5, 2007. cited by applicant .
Document CA/PL 3/08, presented by epi and other Professional Representatives, addressed to the EPO Committee of Patent Law. Presented at the EPO Administrative Council, dated Feb. 14, 2008. cited by applicant .
Summons to Attend Oral Proceedings issued in connection with European Patent Application No. 05019453.9 on Jul. 23, 2010. cited by applicant .
English translation of Office Action issued by Japanese Patent Office in connection with corresponding Japanese Patent Application No. 2001-534353 on May 25, 2010. cited by applicant .
The Office Action issued in connection with Japanese patent application No. 2013-168584 on Sep. 16, 2014. cited by applicant .
Claims Pending in U.S. Appl. No. 12/982,386 on Oct. 20, 2014. cited by applicant .
Claims Pending in U.S. Appl. No. 13/833,263 on Oct. 20, 2014. cited by applicant .
Claims Pending in U.S. Appl. No. 14/094,968 on Oct. 20, 2014. cited by applicant .
Claims Pending in U.S. Appl. No. 14/483,395 on Oct. 20, 2014. cited by applicant .
The Office Action issued in connection with U.S. Appl. No. 12/982,386 on Oct. 9, 2014. cited by applicant .
The Office Action issued in connection with U.S. Appl. No. 12/982,386 on Aug. 13, 2014. cited by applicant .
The Office Action issued in connection with U.S. Appl. No. 12/982,386 on Dec. 19, 2013. cited by applicant .
The Office Action issued in connection with U.S. Appl. No. 12/982,386 on Sep. 4, 2013. cited by applicant .
The Office Action issued in connection with U.S. Appl. No. 12/982,386 on Apr. 30, 2013. cited by applicant .
The Office Action issued in connection with U.S. Appl. No. 12/982,386 on Dec. 27, 2012. cited by applicant .
The Office Action issued in connection with U.S. Appl. No. 12/982,386 on Nov. 5, 2012. cited by applicant .
The Office Action issued in connection with U.S. Appl. No. 12/982,386 on Apr. 10, 2012. cited by applicant .
Claims pending in U.S. Appl. No. 14/612,483 on Feb. 11, 2015. cited by applicant .
The Declaration of Benjamin Oshlack filed in U.S. Appl. No. 13/833,263 on Dec. 24, 2014. cited by applicant .
Claims pending in U.S. Appl. No. 13/833,263 on Jan. 5, 2015. cited by applicant .
Claims pending in U.S. Appl. No. 14/094,968 on Jan. 5, 2015. cited by applicant .
Claims pending in U.S. Appl. No. 12/982,386 on Jan. 5, 2015. cited by applicant .
Claims pending in U.S. Appl. No. 14/483,395 on Jan. 13, 2015. cited by applicant .
An English translation of the Notice on Reexamination issued in connection with Chinese patent application No. 200810125922.X on Dec. 3, 2014. cited by applicant.

Primary Examiner: Sasan; Aradhana
Attorney, Agent or Firm: Davidson, Davidson & Kappel, LLC
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

`abc